Abbott (NYSE: ABT) today announced the U.S. Food and Drug Administration (FDA) has approved the company's Volt™ PFA System to treat patients battling atrial fibrillation (AFib). Abbott will soon begin ...

The FDA approved Abbott's Volt PFA System for atrial fibrillation, supported by VOLT-AF trial data showing strong safety and ...

Ascension St. Vincent’s Riverside is pioneering pulsed field ablation, a non-thermal treatment for atrial fibrillation (AFib). This new technique offers a safer and faster alternative to traditional ...

Abbott (NYSE: ABT) announced today that the FDA approved its Volt pulsed field ablation (PFA) system to treat patients with ...

Dr. Deephak Swaminath and his team at Medical Center Hospital were the first in West Texas to use the Pulse Select PFA (pulsed field ablation) system. Pulse Select PFA is an emerging and newer, ...

Radiofrequency-based ablation for atrial fibrillation appears more effective than previously shown in clinical trials. Using real-world data, a new study found that the procedure eliminated atrial ...

Boston Scientific ($BSX) announced an update on their ongoing clinical study. Study OverviewThis global Boston Scientific trial, officially titled ...

Catheter ablation significantly reduces cardiovascular risks and mortality in patients with both atrial fibrillation and obstructive sleep apnea. The study involved over 18,000 patients, showing a ...

If you sometimes experience a racing or irregular heartbeat, it may be caused by atrial fibrillation (AFib), the most common type of heart arrhythmia. AFib can make you five times more likely to have ...

The efficacy of catheter ablation for heart failure (HF) patients with atrial fibrillation (Afib or AF) hinged on the phenotype of disease, researchers reported based on a meta-analysis. Compared with ...

PANAMA CITY — A local hospital continues working to provide its patients with up-to-date procedures. According to a press release from Ascension Sacred Heart Bay, the facility now offers pulsed field ...